Galectin Therapeutics
GALT
GALT
50 hedge funds and large institutions have $4.85M invested in Galectin Therapeutics in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
50
Holding in Top 10
–
Calls
$730K
Puts
$57K
Top Buyers
| 1 | +$114K | |
| 2 | +$71.3K | |
| 3 | +$11.7K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$8.85K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$4.82K |
Top Sellers
| 1 | -$122K | |
| 2 | -$53K | |
| 3 | -$46K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$39K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$38.7K |